TY - JOUR
T1 - Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme
T2 - an ERS technical standard
AU - Baldwin, David R.
AU - O’Dowd, Emma L.
AU - Tietzova, Ilona
AU - Kerpel-Fronius, Anna
AU - Heuvelmans, Marjolein A.
AU - Snoeckx, Annemiek
AU - Ashraf, Haseem
AU - Kauczor, Hans-Ulrich
AU - Nagavci, Blin
AU - Oudkerk, Matthijs
AU - Putora, Paul Martin
AU - Ryzman, Witold
AU - Veronesi, Giulia
AU - Borondy-Kitts, Andrea
AU - Gratacos, Antoni Rosell
AU - van Meerbeeck, Jan
AU - Blum, Torsten G.
N1 - Funding Information: Conflict of interest: D.R. Baldwin declares honoraria for speaking from AstraZeneca, Roche and MSD, and grants from CRUK, Small Business Research Initiative, NHS Digital, NHS England, NIHR and Horizon 2020, outside the submitted work. H. Ashraf declares a grant from the Norwegian Cancer Society, outside of the work. G. Veronesi declares consulting fees/advisory boards for/from Roche, Medronic, Ab Medica and AstraZeneca, and grants from the Ministry of Health, AIRC and INAIL, outside the submitted work. T.G. Blum declares a grant from the EU4 Health consortium, outside the submitted work. All other authors have no conflicts of interest to declare. Funding Information: Support statement: Supported by the European Respiratory Society (grant: TF-2020-18). Funding information for this article has been deposited with the Crossref Funder Registry. Publisher Copyright: © 2023 European Respiratory Society. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Background Screening for lung cancer with low radiation dose computed tomography (LDCT) has a strong evidence base. The European Council adopted a recommendation in November 2022 that lung cancer screening (LCS) be implemented using a stepwise approach. The imperative now is to ensure that implementation follows an evidence-based process that delivers clinical and cost-effectiveness. This European Respiratory Society (ERS) Task Force was formed to provide a technical standard for a high-quality LCS programme. Method A collaborative group was convened to include members of multiple European societies. Topics were identified during a scoping review and a systematic review of the literature was conducted. Full text was provided to members of the group for each topic. The final document was approved by all members and the ERS Scientific Advisory Committee. Results Topics were identified representing key components of a screening programme. The actions on findings from the LDCT were not included as they are addressed by separate international guidelines (nodule management and clinical management of lung cancer) and by a linked ERS Task Force (incidental findings). Other than smoking cessation, other interventions that are not part of the core screening process were not included (e.g. pulmonary function measurement). 56 statements were produced and areas for further research identified. Conclusions This European collaborative group has produced a technical standard that is a timely contribution to implementation of LCS. It will serve as a standard that can be used, as recommended by the European Council, to ensure a high-quality and effective programme.
AB - Background Screening for lung cancer with low radiation dose computed tomography (LDCT) has a strong evidence base. The European Council adopted a recommendation in November 2022 that lung cancer screening (LCS) be implemented using a stepwise approach. The imperative now is to ensure that implementation follows an evidence-based process that delivers clinical and cost-effectiveness. This European Respiratory Society (ERS) Task Force was formed to provide a technical standard for a high-quality LCS programme. Method A collaborative group was convened to include members of multiple European societies. Topics were identified during a scoping review and a systematic review of the literature was conducted. Full text was provided to members of the group for each topic. The final document was approved by all members and the ERS Scientific Advisory Committee. Results Topics were identified representing key components of a screening programme. The actions on findings from the LDCT were not included as they are addressed by separate international guidelines (nodule management and clinical management of lung cancer) and by a linked ERS Task Force (incidental findings). Other than smoking cessation, other interventions that are not part of the core screening process were not included (e.g. pulmonary function measurement). 56 statements were produced and areas for further research identified. Conclusions This European collaborative group has produced a technical standard that is a timely contribution to implementation of LCS. It will serve as a standard that can be used, as recommended by the European Council, to ensure a high-quality and effective programme.
UR - http://www.scopus.com/inward/record.url?scp=85164475147&partnerID=8YFLogxK
U2 - https://doi.org/10.1183/13993003.00128-2023
DO - https://doi.org/10.1183/13993003.00128-2023
M3 - Article
C2 - 37202154
SN - 0903-1936
VL - 61
JO - European respiratory journal
JF - European respiratory journal
IS - 6
M1 - 2300128
ER -